REC.MI: Recordati Industria Chimica e Farmaceutica S.p.A. Stock Live Price Graph
About the company
Recordati Industria Chimica e Farmaceutica S.p.A., along with its various divisions, functions as a global pharmaceutical firm. Its core operations involve the research, development, production, commercialization, and worldwide distribution of medicinal products. The company's diverse portfolio covers an extensive spectrum of therapeutic areas, including cardiovascular health, dermatology, urology, anti-infectives, central nervous system disorders, gastrointestinal conditions, gynecology, musculoskeletal ailments, and pain management. Furthermore, Recordati supplies over-the-counter remedies, generic drugs, oncology treatments, and solutions for allergies, endocrine issues, and respiratory illnesses, encompassing even ear, nose, and throat preparations. Complementing its pharmaceutical offerings are nutritional products, cosmetics, dietary supplements, and medical devices. Additionally, the firm is a prominent provider of treatments for rare diseases and produces specialized pharmaceutical chemicals, such as active pharmaceutical ingredients (APIs), intermediates, and complex chemical syntheses. Established in Milan, Italy, in 1926, Recordati Industria Chimica e Farmaceutica S.p.A. currently operates as a subsidiary of Rossini S.à R.L.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $0.71 | $0.71 | 2.64% | - |
| - | $0.63 | $0.63 | 2.59% | - |
| - | $0.67 | $0.67 | 2.47% | - |
| - | $0.6 | $0.6 | 2.46% | - |
| - | $0.63 | $0.63 | 2.38% | - |
| - | $0.57 | $0.57 | 2.62% | - |
| - | $0.6 | $0.6 | 2.61% | - |
| - | $0.55 | $0.55 | 2.87% | - |
| - | $0.57 | $0.57 | 2.60% | - |
| - | $0.53 | $0.53 | 1.92% | - |
| - | $0.55 | $0.55 | 2.28% | - |
| - | $0.5 | $0.5 | 2.27% | - |
| - | $0.52 | $0.52 | 2.25% | - |
| - | $0.48 | $0.48 | 2.56% | - |
| - | $0.47 | $0.47 | 2.56% | - |
| - | $0.45 | $0.45 | 3.06% | - |
| - | $0.43 | $0.43 | 2.87% | - |
| - | $0.42 | $0.42 | 2.01% | - |
| - | $0.35 | $0.35 | 2.04% | - |
| - | $0.35 | $0.35 | 2.57% | - |
| - | $0.3 | $0.3 | 2.66% | - |
| - | $0.3 | $0.3 | 2.44% | - |
| - | $0.24 | $0.24 | 2.81% | - |
| - | $0.26 | $0.26 | 2.71% | - |
| - | $0.11 | $0.11 | 2.63% | - |
| - | $0.22 | $0.22 | 3.20% | - |
| - | $0.1 | $0.1 | 3.98% | - |
| - | $0.2 | $0.2 | 4.85% | - |
| - | $0.1 | $0.1 | 5.84% | - |
| - | $0.2 | $0.2 | 8.81% | - |
| - | $0.275 | $0.275 | 4.01% | - |
| - | $0.275 | $0.275 | 4.90% | - |
| - | $0.25 | $0.25 | 5.69% | - |
| - | $0.215 | $0.215 | 4.66% | - |
| - | $0.185 | $0.185 | 2.96% | - |
| - | $0.1375 | $0.1375 | 2.22% | - |
| - | $0.11 | $0.11 | 2.00% | - |
| - | $0.375 | $0.375 | 2.44% | - |
| - | $0.375 | $0.375 | 2.55% | - |
| - | $0.25 | $0.25 | 0.98% | - |
| - | $300 | $300 | 2,149.00% | - |
| - | $600 | $600 | 5,859.38% | - |
| - | $600 | $600 | 6,944.44% | - |
| - | $600 | $600 | 1,536.89% | - |
| - | $600 | $600 | 5,000.00% | - |
| - | $600 | $600 | 3,112.03% | - |
| - | $500 | $500 | 20,161.29% | - |
What Is REC.MI? Live REC.MI Prices and Analysis
REC.MI, also known as Recordati S.p.A., is an Italian pharmaceutical company that specializes in the development and marketing of innovative drugs, primarily in the fields of rare diseases and specialty pharmaceuticals. Established in 1926, Recordati has grown to become a significant player in the global pharmaceutical industry, with a presence in over 150 countries. Investors closely monitor REC.MI due to its strong growth potential, robust pipeline of products, and consistent dividend payments.
The pharmaceutical sector is vital to the global economy, contributing to healthcare advancements and improving the quality of life for millions. Companies like Recordati are essential in addressing unmet medical needs, making their stock an attractive option for investors looking to capitalize on long-term growth in the healthcare market.
Market Context
REC.MI operates in an international market characterized by diverse regulatory environments and varying pricing strategies. The company primarily trades in euros, reflecting its European roots while also engaging in global markets. The pharmaceutical sector is known for its inherent volatility due to factors such as regulatory approvals, patent expirations, and competition from generics. Understanding the market context is crucial for investors looking to make informed decisions regarding REC.MI.
Why Do REC.MI Prices Rise or Fall?
The price of REC.MI shares can be influenced by a variety of factors that investors should consider when evaluating the stock. These factors can lead to significant price fluctuations and impact market sentiment.
- Drug approvals and clinical trial results
- Changes in regulatory policies
- Market competition and the introduction of generics
- Earnings reports and financial performance
- Mergers and acquisitions within the pharmaceutical sector
- Global economic conditions affecting healthcare spending
- Investor sentiment and market speculation
- Technological advancements impacting drug development
Overall, the interplay of these factors can lead to volatility in REC.MI prices, making it essential for investors to stay informed about both the company's developments and broader market trends.
Why Is Live REC.MI Price Tracking Important?
Tracking the live price of REC.MI is vital for investors who wish to make timely decisions based on real-time market data. Understanding price movements can help investors identify trends and potential entry or exit points for their investments.
- Allows for timely investment decisions
- Helps investors gauge market sentiment
- Aids in risk management strategies
- Facilitates the identification of price support and resistance levels
- Enhances understanding of the company's market position
What Should You Consider When Trading / Investing in REC.MI?
Investing in REC.MI involves certain risks and considerations that potential investors should keep in mind. The pharmaceutical industry can be unpredictable, and various macroeconomic factors can significantly affect stock performance.
- Understand the company's product pipeline and potential drug approvals
- Monitor macroeconomic indicators that could affect healthcare spending
- Be aware of the competitive landscape and potential market disruptors
- Evaluate the company's financial health through earnings reports and P/E ratios
- Consider geopolitical risks that may impact international operations
What Can You Find on the Investvio REC.MI Page?
- Live REC.MI stock price and market data
- Comprehensive charts for technical analysis
- Latest news and updates regarding the company
- Detailed earnings reports and financial ratios
- Market sentiment indicators and analyst ratings
The Investvio REC.MI page serves as a valuable resource for investors seeking to stay informed about the stock's performance and the factors affecting its valuation. By leveraging the information provided, investors can make more informed decisions regarding their investments in Recordati S.p.A.